Browse Category

TSX:CRML News 16 October 2025 - 26 January 2026

Critical Metals stock flips lower after early surge as U.S. rare-earth deal jolts sector

Critical Metals stock flips lower after early surge as U.S. rare-earth deal jolts sector

Critical Metals Corp shares fell 9.5% to $18.66 by mid-morning after a volatile start, despite rare-earth stocks initially rising on news of U.S. support for USA Rare Earth’s $1.6 billion financing package. Traders are seeking details on Critical Metals’ Greenland project timeline and funding. USA Rare Earth jumped 15% after announcing federal backing and a $1.5 billion PIPE deal.
26 January 2026
Critical Metals (CRML) stock jumps 10% as Saudi rare-earth talks resurface in filing

Critical Metals (CRML) stock jumps 10% as Saudi rare-earth talks resurface in filing

Critical Metals shares surged about 10% Friday after a filing disclosed a non-binding Saudi MoU and four non-binding offtake term sheets tied to its Tanbreez project. The stock closed at $20.34, up $1.88, with volume over 39 million shares. Traders are watching for binding contracts and further disclosures. The company holds a 42% stake in Tanbreez and aims to expand rare-earth processing.
23 January 2026
Critical Metals CRML stock jumps as Tanbreez offtake term sheets and Greenland headlines draw buyers

Critical Metals CRML stock jumps as Tanbreez offtake term sheets and Greenland headlines draw buyers

Shares of Critical Metals Corp. surged 27% to $19.46 after the company announced a memorandum of understanding with Saudi Arabia’s Al-Qahtani & Brothers for rare-earth concentrate from its Tanbreez project in Greenland. The deal includes plans for joint ventures on processing and refining in Saudi Arabia, though the company said agreements remain non-binding.
Critical Metals (CRML) jumps after Greenland drill assays — what to watch next

Critical Metals (CRML) jumps after Greenland drill assays — what to watch next

Critical Metals shares surged 33% to $17.93 in after-hours trading Wednesday after releasing new drill assay results from its Tanbreez rare earth project in Greenland. Around 60 million shares traded hands amid heavy volatility. The company reported steady grades and significant heavy rare earth content, with more assay results pending. President Trump delayed tariffs on rare earths and lithium, urging officials to secure supplies abroad.
15 January 2026
Critical Metals (CRML) Stock Explodes on Rare-Earth Boom – Gains Skyrocket Amid U.S. Investment Buzz

Critical Metals (CRML) Stock Explodes on Rare-Earth Boom – Gains Skyrocket Amid U.S. Investment Buzz

Stock Price and Recent Performance As of Oct.16, 2025 midday, CRML trades in the mid-$20s, rebounding from Oct.15’s close at $22.72 Marketbeat. That day’s 24% plunge followed a parabolic run higher: in early Oct the stock was only single digits, yet by Oct.13 it hit a 52-week high ($21.45 intraday) and by Oct.14 briefly traded near $32 ts2.tech. These gains made CRML one of the top Nasdaq performers. On Oct.6 alone the stock spiked over 60%, reflecting Reuters’s scoop on a possible U.S. equity investment Reuters ts2.tech. Volume has been enormous – Oct.15 saw ~51 million shares traded ($1.16 billion value) Stockinvest
16 October 2025

Stock Market Today

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

7 February 2026
MARA shares jumped 22.4% to $8.24 Friday, trading higher after hours, as the company moved $87 million in bitcoin to major custodians. About 82.4 million MARA shares changed hands. Bitcoin hovered near $68,928 Saturday. A MARA filing showed its general counsel had shares withheld for taxes on vested stock units, not an open market sale.
Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

7 February 2026
Apple shares closed up 0.8% at $278.12 Friday, then slipped 0.3% after hours. A global DRAM shortage is raising component costs, putting pressure on Apple’s pricing ahead of its Feb. 24 shareholder meeting. CEO Tim Cook said memory prices will rise “sharply” but gave no details on possible iPhone price hikes. Investors await signals before next week’s U.S. inflation data.
Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

7 February 2026
Roivant shares surged 22.4% to $25.82 after Phase 2 data showed its drug brepocitinib outperformed placebo in cutaneous sarcoidosis, with no serious adverse events. The company plans a Phase 3 trial in 2026 and has filed for FDA approval in dermatomyositis. Quarterly revenue reached $2 million, with a $313.7 million loss. Cash holdings stood at $4.5 billion.
Go toTop